Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1813554628;54629;54630 chr2:178604284;178604283;178604282chr2:179469011;179469010;179469009
N2AB1649449705;49706;49707 chr2:178604284;178604283;178604282chr2:179469011;179469010;179469009
N2A1556746924;46925;46926 chr2:178604284;178604283;178604282chr2:179469011;179469010;179469009
N2B907027433;27434;27435 chr2:178604284;178604283;178604282chr2:179469011;179469010;179469009
Novex-1919527808;27809;27810 chr2:178604284;178604283;178604282chr2:179469011;179469010;179469009
Novex-2926228009;28010;28011 chr2:178604284;178604283;178604282chr2:179469011;179469010;179469009
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: G
  • RefSeq wild type transcript codon: GGT
  • RefSeq wild type template codon: CCA
  • Domain: Fn3-19
  • Domain position: 71
  • Structural Position: 102
  • Q(SASA): 0.2205
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
G/D rs776471324 -1.617 0.012 N 0.324 0.262 0.200317383148 gnomAD-2.1.1 5.71E-06 None None None None N None 0 0 None 0 0 None 0 None 0 1.15E-05 0
G/D rs776471324 -1.617 0.012 N 0.324 0.262 0.200317383148 gnomAD-4.0.0 2.257E-06 None None None None N None 0 0 None 0 0 None 0 0 2.86855E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
G/A 0.1451 likely_benign 0.1813 benign -0.58 Destabilizing 0.625 D 0.446 neutral N 0.436630996 None None N
G/C 0.2874 likely_benign 0.3134 benign -0.758 Destabilizing 0.997 D 0.577 neutral N 0.461606799 None None N
G/D 0.5707 likely_pathogenic 0.6897 pathogenic -1.627 Destabilizing 0.012 N 0.324 neutral N 0.495199297 None None N
G/E 0.4234 ambiguous 0.5461 ambiguous -1.541 Destabilizing 0.007 N 0.283 neutral None None None None N
G/F 0.7251 likely_pathogenic 0.8199 pathogenic -0.677 Destabilizing 0.991 D 0.576 neutral None None None None N
G/H 0.5521 ambiguous 0.6524 pathogenic -1.686 Destabilizing 0.993 D 0.518 neutral None None None None N
G/I 0.4419 ambiguous 0.5844 pathogenic 0.266 Stabilizing 0.974 D 0.572 neutral None None None None N
G/K 0.619 likely_pathogenic 0.7343 pathogenic -1.093 Destabilizing 0.067 N 0.298 neutral None None None None N
G/L 0.5289 ambiguous 0.6575 pathogenic 0.266 Stabilizing 0.949 D 0.572 neutral None None None None N
G/M 0.5356 ambiguous 0.6441 pathogenic 0.15 Stabilizing 0.998 D 0.555 neutral None None None None N
G/N 0.4278 ambiguous 0.541 ambiguous -1.059 Destabilizing 0.842 D 0.519 neutral None None None None N
G/P 0.9885 likely_pathogenic 0.9945 pathogenic 0.029 Stabilizing 0.974 D 0.532 neutral None None None None N
G/Q 0.4143 ambiguous 0.5234 ambiguous -1.011 Destabilizing 0.904 D 0.531 neutral None None None None N
G/R 0.4969 ambiguous 0.6006 pathogenic -1.102 Destabilizing 0.876 D 0.504 neutral N 0.419680031 None None N
G/S 0.1171 likely_benign 0.1458 benign -1.36 Destabilizing 0.801 D 0.439 neutral N 0.427299437 None None N
G/T 0.2154 likely_benign 0.2867 benign -1.175 Destabilizing 0.842 D 0.507 neutral None None None None N
G/V 0.3282 likely_benign 0.4478 ambiguous 0.029 Stabilizing 0.966 D 0.571 neutral N 0.415679721 None None N
G/W 0.6916 likely_pathogenic 0.7805 pathogenic -1.403 Destabilizing 0.998 D 0.541 neutral None None None None N
G/Y 0.5957 likely_pathogenic 0.7207 pathogenic -0.807 Destabilizing 0.991 D 0.579 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.